Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes
Clinical trial NCT01918865 · COMPLETED
Trial details
- NCT number
- NCT01918865
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2014-10-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.